SCIMEDX has established itself as a leader in the field of diagnostics, with over 35 years of experience dedicated to enhancing healthcare through accurate and timely diagnosis. The company emphasizes the critical role of diagnostics in modern medicine, asserting that effective treatment is contingent upon precise identification of medical conditions. This commitment to excellence is reflected in their innovative product offerings, which are designed to meet the evolving needs of healthcare providers.

One of the key products offered by SCIMEDX is the Rapid Plasma Reagin (RPR) Test Kit, which is specifically designed for the rapid detection and quantitative determination of syphilis in serum or plasma samples. This test not only aids in the diagnosis of syphilis caused by the Treponema genus but also provides valuable epidemiological data regarding the prevalence of the disease. By offering such advanced diagnostic tools, SCIMEDX plays a vital role in improving patient outcomes and supporting public health initiatives.

United States

SCIMEDX is a diagnostic manufacturer with over 30 years of proven experience. Best known for its  range of autoimmune and infectious disease testing products.

Scimedx extends it's platforms for disease testing. The first was ImmuoCyt+ an FDA cleared & patented assay for bladder cancer.  From there Scimedx expanded it's IFA and Latex Infectious assays by acquiring PANBIO for HHV, Dengue, West Nile. Scimedx then went on to acquire Parasitology serology assays from IVD Research. Continuing it's growth, Scimedx has finalized it's rapid testing platform.

Scimedx is the de-facto manufacturer of IFA, ELISA, Agglutination tests, delivering solutions for disease testing worldwide.

SCIMEDX

Company Details